about
The double face of Morgana in tumorigenesisThe potential of microRNAs in personalized medicine against cancers.A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12.microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas.The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.
P2860
Q26783788-803CA1CE-4065-4D34-B8B8-2105FB5E60EDQ34177547-FC11E4B1-E770-4852-B75C-6AA4B685D307Q35742254-533A82BB-E7A3-4DC1-AC24-C8A59E4B3B08Q38668239-ED375551-02F6-4A12-ADA3-77F3546D8DDEQ38861204-7ABC849C-F071-4136-8E83-CE30FC1197B0Q38891990-47326144-A5D9-496D-BBCB-E980DE2AF9CAQ49519966-562DB41D-0DD2-4B3B-B2B5-56BDFF7EF515
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Akt-ing up on SRPK1: oncogene or tumor suppressor?
@ast
Akt-ing up on SRPK1: oncogene or tumor suppressor?
@en
type
label
Akt-ing up on SRPK1: oncogene or tumor suppressor?
@ast
Akt-ing up on SRPK1: oncogene or tumor suppressor?
@en
prefLabel
Akt-ing up on SRPK1: oncogene or tumor suppressor?
@ast
Akt-ing up on SRPK1: oncogene or tumor suppressor?
@en
P2860
P1433
P1476
Akt-ing up on SRPK1: oncogene or tumor suppressor?
@en
P2093
Alex Toker
P2860
P304
P356
10.1016/J.MOLCEL.2014.04.020
P50
P577
2014-05-01T00:00:00Z